LifeTech Scientific (HKSE:01302) Debt-to-Equity : 0.00 (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific Debt-to-Equity?

LifeTech Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$7 Mil. LifeTech Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$3 Mil. LifeTech Scientific's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$3,686 Mil. LifeTech Scientific's debt to equity for the quarter that ended in Dec. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for LifeTech Scientific's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of LifeTech Scientific was 0.81. The lowest was 0.00. And the median was 0.08.

HKSE:01302's Debt-to-Equity is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

LifeTech Scientific Debt-to-Equity Historical Data

The historical data trend for LifeTech Scientific's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Debt-to-Equity Chart

LifeTech Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.31

0.08

0.01

LifeTech Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.01	-	-	-	-

Competitive Comparison of LifeTech Scientific's Debt-to-Equity

For the Medical Devices subindustry, LifeTech Scientific's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeTech Scientific's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's Debt-to-Equity falls into.

LifeTech Scientific Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

LifeTech Scientific's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.883	+	3.285)	/	3686.3
	=	0.00

LifeTech Scientific's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.883	+	3.285)	/	3686.3
	=	0.00

LifeTech Scientific (HKSE:01302) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

LifeTech Scientific Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeTech Scientific (HKSE:01302) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

LFTSF:USA 81X:Germany

Address

No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063

Website

http://www.lifetechmed.com

LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

Executives

Xie Yuehui	2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited	2101 Beneficial owner
Hhlr Advisors, Ltd.	2102 Investment manager
Bank Of Communications Trustee Limited	2301 Trustee
Xie Yuehui	2201 Interest of corporation controlled by you
Hhlr Fund, L.p.	2101 Beneficial owner
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines